Home » Authors » Cynthia Robbins-Roth

Articles by Cynthia Robbins-Roth

Need Public Market Access? Go Knock On Heaven’s Door (Corp.)

March 27, 2006

By Cynthia Robbins-Roth

A Kinder, Gentler Place For Biotech Hallmark: Start-ups

March 13, 2006

By Cynthia Robbins-Roth

A Kinder, Gentler Place For Biotech Hallmark: Start-ups

March 13, 2006

By Cynthia Robbins-Roth

Love, Gambling And Biotech: Side Effects Of CNS Drugs

Feb. 27, 2006

By Cynthia Robbins-Roth

Love, Gambling And Biotech: Side Effects Of CNS Drugs

Feb. 27, 2006

By Cynthia Robbins-Roth

Deal Terms Reward Products: No Surprise From 2005 Trends

Feb. 13, 2006

By Cynthia Robbins-Roth

Deal Terms Reward Products: No Surprise From 2005 Trends

Feb. 13, 2006

By Cynthia Robbins-Roth

Much Like Peter Pan, Big Pharma Won't Grow Up

Jan. 30, 2006

By Cynthia Robbins-Roth

Much Like Peter Pan, Big Pharma Won't Grow Up

Jan. 30, 2006

By Cynthia Robbins-Roth

Biotech's Redemption Chance: Make Drugs, Foster Community

Jan. 17, 2006

By Cynthia Robbins-Roth

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.